Polycythaemia vera patients can present with arterial or venous vascular occlusive events such as thrombosis or cardiovascular disease; disease-related symptoms may significantly impact on the quality ...

Takeda has bolstered its near-term pipeline in rare haematological disorders by licensing rights to a polycythaemia vera (PV) treatment being developed by Protagonist Therapeutics. The Japanese ...

She also reported a history of anhidrosis. She was known to have polycythaemia vera and had been taking hydroxyurea for many years. On examination, symmetrical keratotic, flat, and polygonal ...

Anaemia in myelofibrosis is a multifaceted challenge with a significant impact on patient outcomes, writes Theresa Lowry ...

Opzelura is a topical version of Incyte's oral drug Jakafi/Jakavi, which is FDA approved for myelofibrosis, polycythaemia vera and graft-versus-host-disease, and has been billed as a major growth ...

A Central Queensland couple is celebrating their own Christmas miracle after their premature twin baby girls finally came ...

Guidance on the use of capecitabine and tegafur with uracil for metastatic colorectal cancer TA61 27 May 2003 27 May 2003 Guidance on the use of drugs for early thrombolysis in the treatment of acute ...

Cinacalcet for the treatment of secondary hyperparathyroidism in patients with end-stage renal disease on maintenance dialysis therapy TA117 24 January 2007 24 January 2007 Methadone and buprenorphine ...

Erythroblasts possess unique characteristics as they undergo differentiation from hematopoietic stem cells. During terminal erythropoiesis, these cells incorporate large amounts of iron in order to ...

While in utero, the twins faced risks from Twin Anaemia Polycythaemia Sequence and Twin-to-Twin Transfusion Syndrome. The conditions occur in identical twins sharing one placenta and can cause ...